Muhammad Farhan

Effect of SGLT2 inhibitors on arrhythmic and device-therapy outcomes in heart failure patients with ICD/CRT-D: a systematic review and meta-analysis

Background Sodium-glucose cotransporter-2 inhibitors (SGLT2i) improve heart failure outcomes, but their association with arrhythmic events and device-therapy endpoints in patients with implantable cardioverter-defibrillator (ICD) or cardiac resynchronization therapy-defibrillator...